Spiroxatrine
Jump to navigation
Jump to search
Spiroxatrine (Spiroxamide, R5188) is a drug which acts as a selective antagonist at both the 5-HT1A receptor and the α2C adrenergic receptor.[1] It is an analog of spiperone and also has some dopamine antagonist effects and a relatively weak opioid action.[2][3]
References
<templatestyles src="Reflist/styles.css" />
- ↑ Script error: No such module "Citation/CS1".
- ↑ NIEMEGEERS CJ, VERBRUGGEN FJ, VANNUETEN JM, JANSSEN PA. SPIROXAMIDE (R 5188): A NEW COMPOUND PRODUCING MORPHINE-LIKE AND CHLORPROMAZINE-LIKE EFFECTS IN ANIMALS. Int J Neuropharmacol. 1963 Dec;2:349-54. Script error: No such module "CS1 identifiers". Template:Pmid
- ↑ Leysen J, Tollenaere JP, Koch MHJ, Laduron P. Differentiation of opiate and neuroleptic receptor binding in rat brain. European Journal of Pharmacology 1977; 43(3):253-267. Script error: No such module "CS1 identifiers".
Script error: No such module "Check for unknown parameters".
Script error: No such module "navboxes". Template:Adrenergic receptor modulators Template:Dopamine receptor modulators Template:Serotonin receptor modulators Template:Xenobiotic-sensing receptor modulatorsScript error: No such module "navboxes".Script error: No such module "Check for unknown parameters".